Back
PharmaCyte Biotech, Inc. 10K Form
Sell
40
PMCB
PharmaCyte Biotech, Inc.
Last Price:
$0.70
Seasonality Move:
1.7%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PMCB News And Ratings
See the #1 stock for the next 7 days that we like better than PMCB
PMCB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-786.8K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.55 |
| Price / Book: | 0.2 |
Profitability
| EPS (TTM): | -1.04060 |
|---|---|
| Net Income (TTM): | $-3.3M |
| Gross Margin: | $0 |
| Return on Equity: | -7.78% |
| Return on Assets: | -6.41% |
PharmaCyte Biotech, Inc. Earnings Forecast
Key PharmaCyte Biotech, Inc. Financial Ratios
-
The Interest Expense is 0.00% of Operating Income.
-
Per Share Earnings over the last 24 years have been positive in 11 years.
PharmaCyte Biotech, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PMCB |
| Website: | pharmacyte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.33 |
| Quick Ratio: | 12.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0.22 |
|---|---|
| Forward P/E Ratio: | 0 |
PMCB Technical Analysis vs Fundamental Analysis
Sell
40
PharmaCyte Biotech, Inc. (PMCB)
is a Sell
Is PharmaCyte Biotech, Inc. a Buy or a Sell?
-
PharmaCyte Biotech, Inc. stock is rated a SellThe current PharmaCyte Biotech, Inc. [PMCB] share price is $0.69. The Score for PMCB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.